Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000915 · ClinicalTrials.gov registry record · NA
An HIV Vaccine Preparedness Study
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 4,892
- Enrollment target
NCT00000915: Completed NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00000915 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 4,892 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (248% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000915, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 4,892 participants
- Enrollment target
Study Summary
The purpose of this study is to estimate the rate at which a certain population becomes infected with HIV. The individuals examined in this study are people who are expected to take part in future studies of HIV vaccines and nonvaccine HIV prevention studies. This study also examines the chances of becoming HIV-positive based on certain risk factors under conditions that are similar to the conditions that would exist in HIV vaccine and non-HIV prevention studies. Before studying the effectiveness of a potential HIV vaccine, it is important to learn about the range of HIV risk behaviors in the potential participants of these studies. The probability of HIV infection associated with these risk behaviors should also be examined. This study is designed to increase the ability of HIVNET to put into place HIV prevention trials, to increase the diversity of trial participants, and to target populations at highest risk for HIV infection.
Interventions
- BEHAVIORAL Vaccine preparedness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,892 participants |
| Phase | NA |
What the finished NCT00000915 record still lists
NCT00000915 is an interventional study that assigns participants to a tested intervention. Its 4,892 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (248% higher).
The record links to 0 conditions, and to 1 intervention - of which Vaccine preparedness is the first listed.
NCT00000915 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000915 about?
NCT00000915 is a clinical study titled "An HIV Vaccine Preparedness Study". The purpose of this study is to estimate the rate at which a certain population becomes infected with HIV. The individuals examined in this study are people who are expected to take part in future studies of HIV vaccines and nonvaccine HIV prevention studies. This study also examines the chances of ...
What is the current status of trial NCT00000915?
This trial is currently completed. It is a NA study. The enrollment target is 4,892 participants.
What interventions are being tested in trial NCT00000915?
The interventions under investigation include: Vaccine preparedness (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000915?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000915's enrollment target sits among peer trials
4,892 28th of 2000 higher than 1,973 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05929976 · 4,900 participants
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program